Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7812010 | 0.82 | TSHR (0.37) | TSHR | |
| SCHEMBL4436411 | 0.79 | TSHR (0.35) | TSHR | |
| SCHEMBL14663990 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL440846 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL12219513 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL7990072 | 0.76 | LMNA (0.44) | TSHRLMNA | |
| SCHEMBL12219511 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL205358 | 0.74 | — | — | |
| SCHEMBL9239211 | 0.73 | TSHR (0.38) | TSHR | |
| SCHEMBL8526845 | 0.73 | TSHR (0.32) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119286493-B | Hydrocarbon carbon dioxide gas-soluble foaming agent composition and preparation method thereof | 中国石油大学(华东) | 2025-02-11 | — | — | CN | claimed |
| CN-119286493-A | Hydrocarbon carbon dioxide gas-soluble foaming agent composition and preparation method thereof | 中国石油大学(华东) | 2025-01-10 | — | — | CN | claimed |
| CN-119264411-A | Amidized polymethyl hydrocarbon ether gas-soluble foaming agent and preparation method thereof | 中国石油大学(华东) | 2025-01-07 | — | — | CN | claimed |
| WO-2015121476-A1 | METHOD FOR HYDROGENATING CARBON DIOXIDE INTO FORMATE | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-08-20 | — | — | WO | claimed |
| WO-2015121357-A1 | METHOD FOR HYDROGENATING CARBON DIOXIDE INTO FORMAMIDES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-08-20 | — | — | WO | claimed |
| US-7164042-B2 | Method for making 2,2,4,4,-tetramethyl-3-pentanone oxime and hydroxylammonium salts | FLUOROTECH, LLC (US) | 2007-01-16 | — | — | US | claimed |
| EP-1399415-B1 | METHOD FOR MAKING 2,2,4,4-TETRAMETHYL-3-PENTANONE OXIME AND HYDROXYLAMMONIUM SALTS | FLUOROTECH LLC (US) | 2005-03-16 | — | — | EP | claimed |
| US-20040162443-A1 | Method for making 2,2,4,4-tetramethyl-3-pentanone oxime and hydroxylammonium salts | FLUOROTECH, LLC | 2004-08-19 | — | — | US | claimed |
| CN-1512981-A | Method for making 2,2,4,4-tetramethyl-3-pentanone oxime and hydroxylammonium salts | �����ι�˾ | 2004-07-14 | — | — | CN | claimed |
| EP-1399415-A1 | METHOD FOR MAKING 2,2,4,4-TETRAMETHYL-3-PENTANONE OXIME AND HYDROXYLAMMONIUM SALTS | Fluorotech, LLC (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002098842-A1 | METHOD FOR MAKING 2,2,4,4-TETRAMETHYL-3-PENTANONE OXIME AND HYDROXYLAMMONIUM SALTS | FLUOROTECH LLC (US) | 2002-12-12 | — | — | WO | claimed |
| WO-2002083553-A1 | METHOD FOR MAKING HYDROGEN PEROXIDE | FLUOROTECH, LLC (US) | 2002-10-24 | — | — | WO | claimed |
| WO-1990005141-A1 | AMINO ACID AND PEPTIDE INHIBITORS OF HUMAN LEUKOCYTIC ELASTASE AND COLLAGENASE | AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) | 1990-05-17 | — | — | WO | claimed |
| EP-3191437-B1 | PROCESS FOR HYDROXYLATING PHENOLIC SUBSTRATE | SPECIALTY OPERATIONS FRANCE (FR) | 2025-10-01 | — | — | EP | disclosed |
| US-12390437-B2 | Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response | SITRYX THERAPEUTICS LIMITED (GB) | 2025-08-19 | — | — | US | disclosed |
| EP-3962602-B1 | ITACONIC ACID DERIVATIVES AND USES THEREOF IN TREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE | SITRYX THERAPEUTICS LTD (GB) | 2025-06-25 | — | — | EP | disclosed |
| EP-0203539-A1 | L-Aminodicarboxylic acid amides of alkoxyalkylamines and an edible composition containing same | GENERAL FOODS CORPORATION (US) | 1986-12-03 | — | — | EP | disclosed |
| US-4603011-A | ARTIFICIAL SWEETRENERS | GENERAL FOODS CORPORATION (US) | 1986-07-29 | — | — | US | disclosed |
| US-4072722-A | OXIDIZING A MONOHYDRIC PHENOL WITH A KETONE PEROXIDE | UBE INDUSTRIES, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
| US-4013727-A | OXIDATION OF PHENYL ETHERS WITH HYDROGEN PEROXIDE | UBE INDUSTRIES, LTD. (JA) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390437-B2 | Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response | IL1R1, IL1B, IL1A | TSHR 3856/4885ALDH1A1 9/4885LMNA 4495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.